<?xml version="1.0" encoding="UTF-8"?>
<svg height="813.2" width="537.5" xmlns="http://www.w3.org/2000/svg">
 <g>
  <text svgx:width="0.61,0.61,0.67,0.56,0.33,0.25,0.44,0.5,0.5,0.39,0.5,0.5,0.28,0.25,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.5,0.25,0.33,0.5,0.5,0.67,0.25,0.5,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.5,0.25" y="44.8" x="315.6,321.4,327.2,333.5,338.8,342.0,344.4,348.6,353.3,358.1,361.7,366.5,371.2,373.9,376.3,381.1,385.8,390.6,395.3,398.5,403.2,408.0,411.1,415.9,420.6,425.3,430.1,433.3,438.1,442.8,447.6,452.3,454.7,459.5,461.9,465.0,469.8,474.5,480.8,483.2,488.0,492.8,497.5,502.3,505.4,510.2,514.9,519.7,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">EXCLI Journal 2017;16:1103-1113 – ISSN 1611-2156 </text>
  <text svgx:width="0.61,0.44,0.44,0.44,0.28,0.44,0.44,0.5" y="55.7" x="217.3,223.1,227.3,231.5,235.7,238.4,242.6,246.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Received</text>
  <text svgx:width="0.28" y="55.7" x="251.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.44,0.5,0.5,0.44,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.44,0.44,0.44,0.5,0.28,0.44,0.5" y="55.7" x="254.2,256.6,260.8,265.5,270.3,274.5,276.9,281.7,286.4,288.8,291.2,295.9,300.7,305.4,310.2,312.6,315.0,319.7,323.9,328.1,332.4,337.1,339.8,344.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> June 26, 2017, accepted</text>
  <text svgx:width="0.28" y="55.7" x="348.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.28,0.28,0.39,0.5,0.44,0.5" y="55.7" x="351.2,353.6,359.4,364.2,368.9,373.7,377.4,380.0,382.4,387.2,391.9,394.3,396.7,401.4,406.2,410.9,415.7,418.0,420.4,425.2,429.9,434.7,437.3,440.0,443.6,448.4,452.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> August 17, 2017, published</text>
  <text svgx:width="0.28" y="55.7" x="457.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">:</text>
  <text svgx:width="0.25,0.61,0.5,0.5,0.5,0.39,0.28,0.25,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.25" y="55.7" x="460.0,462.4,468.2,473.0,477.7,482.5,486.1,488.8,491.2,495.9,500.7,503.1,505.5,510.2,514.9,519.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:9.5px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> August 29, 2017 </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.25" y="803.2" x="285.7,291.7,297.7,303.7,309.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">1104 </text>
  <text svgx:width="0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25,0.39,0.5,0.44,0.5,0.25,0.44,0.39,0.25,0.28,0.5,0.78,0.5,0.33,0.25,0.5,0.44,0.44,0.33,0.5,0.39,0.28,0.39,0.25,0.33,0.44,0.44,0.33" y="96.1" x="70.9,80.2,85.5,88.8,94.9,98.9,104.9,108.2,113.5,119.5,122.9,128.8,134.8,138.2,144.2,149.5,154.2,157.5,162.2,168.1,173.4,179.4,182.7,188.1,192.7,196.0,199.4,205.4,214.6,220.6,224.6,227.9,234.0,239.3,244.6,248.6,254.6,259.3,262.7,267.3,270.6,274.6,280.0,285.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">matory cytokines such as tumor necrosis fac-</text>
  <text svgx:width="0.28,0.5,0.33,0.25,0.55,0.33,0.61,0.72,0.56,0.33,0.33,0.52,0.25,0.25,0.55,0.28,0.5,0.28,0.44,0.33,0.28,0.44,0.5,0.5,0.28,0.5,0.25,0.55,0.33,0.33,0.61,0.33,0.33,0.5,0.51,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.61,0.33,0.5,0.25,0.25" y="109.9" x="70.9,74.3,80.3,84.3,87.3,90.0,94.0,101.4,110.1,116.7,120.7,124.7,131.0,134.0,137.0,139.8,143.1,149.1,152.5,157.8,161.8,165.2,170.5,176.5,182.5,185.9,191.8,194.8,197.6,201.6,205.6,212.9,216.9,220.9,226.9,233.0,236.0,239.0,241.8,247.1,253.1,259.1,262.1,264.9,268.9,276.2,280.2,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">tor (TNF)-α, interleukin (IL)-1β, and IL-6, </text>
  <text svgx:width="0.44,0.5,0.5,0.25,0.55,0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.33,0.44,0.44,0.28,0.5,0.33,0.39,0.25,0.55,0.39,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.5,0.28,0.28,0.33,0.28,0.44,0.25" y="123.7" x="70.9,76.2,82.2,88.2,91.2,93.4,99.4,103.4,109.4,113.4,116.7,122.7,126.7,130.0,135.4,144.7,154.0,159.3,162.7,168.7,172.7,178.7,181.7,183.8,187.8,193.1,198.5,201.8,207.8,211.8,216.4,219.4,221.6,226.3,232.3,237.6,243.5,246.5,248.7,254.0,258.7,261.7,263.8,269.8,273.2,276.5,280.5,283.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and pro-inflammatory factors such as nitric </text>
  <text svgx:width="0.5,0.5,0.28,0.5,0.44,0.25,0.33,0.72,0.72,0.33,0.25,0.25,0.5,0.33,0.5,0.39,0.28,0.44,0.5,0.28,0.44,0.5,0.5,0.28,0.5,0.25,0.61" y="137.5" x="70.9,76.9,82.9,86.3,92.3,97.6,100.6,104.6,113.2,121.9,125.9,128.9,131.9,137.9,141.9,147.9,152.6,155.9,161.2,167.2,170.6,175.9,181.9,187.9,191.2,197.2,200.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">oxide (NO), prostaglandin E</text>
  <text svgx:width="0.5" y="137.9" x="207.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.25,0.33,0.56,0.72,0.61" y="137.5" x="211.6,214.6,218.5,225.2,233.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> (PGE</text>
  <text svgx:width="0.5" y="137.9" x="241.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.33,0.25,0.25,0.28,0.5,0.5,0.5,0.44,0.28,0.33" y="137.5" x="245.2,249.2,252.2,255.2,258.5,264.5,270.5,276.5,281.8,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">), induci-</text>
  <text svgx:width="0.5,0.28,0.44,0.25,0.55,0.5,0.28,0.28,0.33,0.28,0.44,0.25,0.55,0.5,0.5,0.28,0.5,0.44,0.25,0.55,0.39,0.5,0.5,0.28,0.5,0.44,0.39,0.44,0.25,0.55,0.33,0.28,0.72,0.72,0.56,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.33" y="151.3" x="70.9,76.9,80.3,85.6,88.6,92.1,98.1,101.5,104.8,108.8,112.2,117.5,120.5,124.0,130.0,136.0,139.4,145.4,150.7,153.7,157.3,161.9,167.9,174.0,177.3,183.3,188.6,193.3,198.6,201.6,205.2,209.2,212.5,221.2,229.9,236.5,240.5,243.5,246.5,250.1,255.4,261.4,267.4,270.4,274.0,279.3,285.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ble nitric oxide synthase (iNOS), and cy-</text>
  <text svgx:width="0.44,0.28,0.5,0.5,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.44,0.25,0.55,0.33,0.67,0.72,0.72,0.33,0.33,0.5,0.25,0.55,0.33,0.61,0.28,0.5,0.5,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.25" y="165.1" x="70.9,76.2,79.6,85.6,91.6,97.6,103.6,109.6,114.9,120.9,126.2,130.9,136.2,139.2,141.5,145.5,153.5,162.2,170.8,174.8,178.8,184.8,187.8,190.1,194.1,201.4,204.8,210.8,216.8,222.8,225.8,228.0,233.4,236.7,239.7,242.0,247.3,250.6,253.6,256.6,259.6,261.9,267.9,273.9,279.9,285.9,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">clooxygenase (COX)-2 (Ljung et al., 2006; </text>
  <text svgx:width="0.94,0.44,0.28,0.39,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.33,0.44,0.33,0.5,0.33,0.44,0.25,0.25,0.55,0.28,0.5,0.5,0.28,0.5,0.28,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" y="178.9" x="70.9,82.3,87.6,90.9,95.6,101.6,104.6,106.0,111.3,114.7,117.7,119.0,124.4,127.7,130.7,133.7,136.7,138.0,144.0,150.1,156.1,162.1,166.1,169.1,172.1,173.5,180.8,186.8,192.1,196.1,201.5,205.5,211.5,215.5,220.8,223.8,226.8,228.2,231.5,237.5,243.5,246.8,252.8,256.1,259.5,262.8,268.8,274.8,277.8,279.2,285.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Walsh et al., 2005). Therefore, inhibition of </text>
  <text svgx:width="0.28,0.5,0.44,0.39,0.44,0.25,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.28,0.39,0.25,0.44,0.5,0.25,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25" y="192.7" x="70.9,74.3,80.3,85.6,90.3,95.6,98.6,101.9,107.9,111.9,115.3,120.6,130.0,139.2,144.5,147.9,153.9,157.9,163.9,167.0,176.2,181.6,187.6,190.9,196.2,199.6,205.6,209.6,214.3,217.2,220.6,225.3,228.2,233.5,239.6,242.5,245.9,255.2,261.2,267.2,271.2,274.6,279.9,285.9,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">these inflammatory mediators is an important </text>
  <text svgx:width="0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.55,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.78,0.44,0.5,0.28,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.28,0.39,0.44,0.44,0.39,0.44,0.39,0.25" y="206.5" x="70.9,74.3,79.6,83.6,89.6,94.9,98.3,101.3,103.6,109.6,114.9,118.3,124.2,132.9,138.2,144.2,147.2,149.5,152.9,158.9,161.9,164.1,167.5,173.5,178.8,181.8,184.1,187.5,191.5,196.8,202.1,205.5,214.7,220.0,226.0,229.4,232.4,234.7,240.7,244.7,247.7,250.0,256.0,259.3,264.0,269.4,274.7,279.3,284.7,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">target pathway in the treatment of diseases </text>
  <text svgx:width="0.72,0.28,0.28,0.5,0.25,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.78,0.5,0.5,0.5,0.44,0.5,0.28,0.39,0.25,0.25,0.25" y="220.3" x="70.9,79.6,82.9,86.3,92.3,95.3,100.6,106.6,110.0,113.3,117.3,120.7,126.7,130.6,133.9,139.2,148.6,157.8,163.2,166.5,172.5,176.5,182.5,185.5,190.9,196.9,206.1,212.1,218.1,224.1,229.5,235.5,238.8,243.5,246.5,249.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">with anti-inflammatory components. </text>
  <text svgx:width="0.72,0.5,0.44,0.28,0.44,0.44,0.33,0.25,0.28,0.33,0.44,0.5,0.39,0.44,0.33,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.33,0.44,0.44,0.28,0.5,0.33,0.25,0.5,0.44,0.5,0.5,0.44,0.33,0.67,0.25,0.33,0.72,0.56,0.33" y="234.1" x="88.8,97.5,103.5,108.8,112.2,117.5,122.9,126.9,129.3,132.6,136.6,142.0,147.9,152.6,157.9,161.9,165.3,171.2,174.6,177.9,183.9,190.0,192.4,196.4,201.7,207.1,210.4,216.4,220.4,222.8,228.8,234.1,240.1,246.1,251.4,255.4,263.4,265.9,269.8,278.5,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Nuclear transcription factor kappa-B (NF-</text>
  <text svgx:width="0.5,0.67,0.33,0.25,0.55,0.33,0.44,0.5,0.5,0.28,0.44,0.28,0.44,0.39,0.25,0.55,0.44,0.25,0.55,0.5,0.44,0.33,0.28,0.44,0.28,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.44,0.39,0.25,0.55,0.44,0.39,0.39,0.5,0.44,0.28,0.44,0.28,0.44,0.5,0.25" y="247.9" x="70.9,77.0,85.0,89.0,92.0,94.3,98.2,103.6,109.6,115.6,118.9,124.2,127.6,132.9,137.6,140.6,142.8,148.2,151.2,153.4,159.4,164.8,168.8,172.1,177.4,180.7,186.7,189.7,192.0,198.0,202.0,205.0,207.3,213.3,218.6,224.6,229.9,234.6,237.6,239.9,245.2,249.9,254.5,260.5,265.9,269.2,274.5,277.9,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">κB) regulates a variety of genes associated </text>
  <text svgx:width="0.72,0.28,0.28,0.5,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.44,0.5,0.28,0.44,0.33,0.5,0.5,0.44,0.39,0.44,0.25,0.55,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25" y="261.7" x="70.9,79.6,82.9,86.3,92.3,95.3,96.8,100.2,109.5,118.9,124.9,130.9,136.2,139.2,140.8,146.1,152.1,158.1,161.1,162.7,168.0,173.3,179.4,182.7,188.0,192.0,198.0,204.0,209.3,214.0,219.3,222.3,223.9,227.2,233.3,237.2,240.6,245.9,255.2,264.5,269.9,273.2,279.2,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">with immune and acute-phase inflammatory </text>
  <text svgx:width="0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.25,0.55,0.61,0.5,0.44,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.56,0.33,0.5,0.67,0.25,0.55,0.5,0.5,0.44,0.25,0.55,0.28,0.5,0.25" y="275.5" x="70.9,74.9,80.3,84.9,90.9,96.9,102.9,107.6,112.9,117.6,120.6,123.6,126.0,133.3,139.3,144.7,147.7,150.1,155.4,160.7,164.1,167.4,173.4,178.7,182.1,185.4,191.4,197.4,200.4,202.8,208.8,212.8,215.8,218.2,226.9,233.5,237.5,243.7,251.7,254.7,257.1,263.1,269.1,274.4,277.4,279.8,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">responses. The activation of NF-κB due to </text>
  <text svgx:width="0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.28,0.39,0.25,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.44,0.5,0.25,0.5,0.5,0.25" y="289.3" x="70.9,76.9,80.9,86.9,90.9,94.3,100.3,104.3,107.6,113.0,122.3,131.7,137.0,140.3,146.3,150.3,156.4,160.1,164.7,168.1,171.4,180.7,186.7,190.0,195.3,198.7,202.0,208.0,214.1,217.8,221.1,225.8,229.5,232.8,238.8,244.8,248.2,253.5,258.8,262.2,267.5,273.5,277.2,283.2,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">pro-inflammatory stimulation is indicated by </text>
  <text svgx:width="0.33,0.44,0.5,0.28,0.5,0.25,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.5,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.5,0.33,0.44,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.28,0.5,0.33" y="303.1" x="70.9,74.9,80.2,86.2,89.6,95.6,99.2,105.2,111.2,117.2,121.9,127.9,133.9,139.9,143.9,149.9,153.2,158.6,161.9,165.2,171.2,177.2,180.9,186.2,192.2,198.2,201.9,207.9,213.2,219.2,223.2,228.5,234.5,239.9,243.2,246.5,252.5,258.5,262.2,268.2,272.2,275.9,279.2,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">rapid phosphorylation and degradation of in-</text>
  <text svgx:width="0.5,0.28,0.5,0.28,0.28,0.5,0.33,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.5,0.44,0.5,0.5,0.44,0.25,0.55,0.67,0.25,0.55,0.33,0.33,0.5,0.67,0.39,0.33,0.25,0.55,0.33,0.67,0.44,0.28,0.44,0.5,0.44,0.5,0.39,0.44,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25" y="316.9" x="70.9,76.9,80.2,86.2,89.6,92.9,98.9,102.9,107.5,110.5,111.5,117.5,121.5,124.5,125.4,131.4,136.8,142.7,148.7,154.1,157.1,158.0,166.0,169.0,170.0,174.0,178.0,184.1,192.1,196.8,200.8,203.8,204.7,208.7,216.7,222.1,225.4,230.7,236.7,242.1,248.1,252.7,258.0,261.0,262.0,267.3,270.7,273.7,274.6,280.0,283.3,286.3,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">hibitors of kappa B (IκBs) (Rajapakse et al., </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.56,0.33,0.44,0.44,0.5,0.25,0.72,0.56,0.33,0.5,0.67,0.25,0.5,0.28,0.78,0.44,0.33,0.39,0.25,0.33,0.33,0.5,0.78,0.25,0.28,0.5,0.28,0.39,0.25,0.5,0.33,0.5,0.44,0.44,0.39,0.39,0.25" y="330.7" x="70.9,76.9,82.9,88.9,94.9,98.9,101.9,104.8,111.5,115.4,120.8,126.1,132.1,135.0,143.6,150.3,154.3,160.4,168.4,171.3,177.3,180.6,189.9,195.3,199.3,203.9,206.8,210.8,214.8,220.8,230.0,232.9,236.3,242.3,245.6,250.3,253.1,259.1,263.1,269.1,274.5,279.8,284.5,289.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2008). Freed NF-κB dimers from this process </text>
  <text svgx:width="0.28,0.33,0.44,0.5,0.39,0.28,0.5,0.44,0.44,0.28,0.44,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.5,0.44,0.28,0.44,0.5,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.33" y="344.5" x="70.9,74.3,78.3,83.6,89.6,94.2,97.6,103.6,108.9,114.2,117.6,122.9,125.8,129.1,135.1,138.0,141.3,147.3,152.7,155.5,161.5,167.5,172.9,176.2,181.5,187.5,192.2,195.1,200.4,206.4,212.4,215.3,221.3,224.6,230.6,236.6,239.5,242.8,248.8,251.7,255.0,261.0,266.3,269.2,275.2,279.2,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">translocate to the nucleus and bind to the pro-</text>
  <text svgx:width="0.78,0.5,0.28,0.44,0.33,0.25,0.55,0.33,0.44,0.5,0.28,0.5,0.5,0.39,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.44,0.33,0.5,0.44,0.28,0.25,0.55,0.5,0.44,0.5,0.44,0.39,0.25,0.55,0.33,0.61,0.44,0.44,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25" y="358.3" x="70.9,80.3,86.3,89.6,94.9,98.9,101.9,105.4,109.4,114.7,120.7,124.0,130.0,136.0,140.7,143.7,147.1,153.1,157.1,160.1,163.6,166.9,172.2,176.2,182.2,187.6,190.9,193.9,197.3,203.3,208.7,214.7,220.0,224.7,227.7,231.1,235.1,242.4,247.7,253.1,256.1,259.5,264.8,268.2,271.2,274.6,279.9,283.3,286.3,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">moter regions of target genes (Lee et al., </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.5,0.25,0.55,0.28,0.5,0.5,0.5,0.44,0.44,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.28,0.33,0.44,0.5,0.39,0.44,0.33,0.28,0.5,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" y="372.1" x="70.9,76.9,82.9,88.9,94.9,98.9,101.9,104.9,106.0,113.4,119.4,124.7,130.7,133.7,134.8,138.1,144.1,149.4,155.5,158.5,159.5,162.9,168.9,174.9,180.9,186.2,191.5,194.5,195.6,199.0,205.0,210.3,213.3,214.4,217.7,221.7,227.1,233.1,237.7,243.1,247.1,250.4,256.4,259.7,263.1,269.1,275.1,278.1,279.2,285.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2003). They then induce the transcription of </text>
  <text svgx:width="0.5,0.33,0.5,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.33,0.39,0.25,0.55,0.39,0.5,0.44,0.5,0.25,0.55,0.44,0.39,0.25,0.55,0.28,0.72,0.72,0.56,0.25,0.25" y="385.9" x="70.9,76.9,80.9,86.9,90.9,94.3,100.3,104.3,107.6,113.0,122.3,131.7,137.0,140.3,146.3,150.3,156.4,159.4,162.2,171.4,176.7,182.8,186.1,191.4,194.8,200.8,204.8,209.5,212.5,215.3,219.9,225.9,231.3,237.3,240.3,243.1,248.4,253.1,256.1,258.9,262.3,270.9,279.6,286.3,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">pro-inflammatory mediators such as iNOS, </text>
  <text svgx:width="0.67,0.72,0.72,0.33,0.5,0.25,0.25,0.55,0.33,0.61,0.33,0.5,0.25,0.25,0.55,0.33,0.61,0.33,0.5,0.51,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.61,0.72,0.56,0.33,0.52,0.25,0.55,0.33,0.89,0.44,0.5,0.44,0.33,0.5,0.5,0.25,0.25" y="399.7" x="70.9,78.9,87.6,96.3,100.3,106.3,109.3,112.3,114.2,118.2,125.5,129.5,135.5,138.5,141.5,143.4,147.4,154.8,158.8,164.8,170.9,173.9,176.9,178.8,184.1,190.1,196.1,199.1,201.0,208.3,217.0,223.6,227.6,233.9,236.9,238.9,242.9,253.5,258.9,264.9,270.2,274.2,280.2,286.3,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">COX-2, IL-6, IL-1β, and TNF-α (Makarov, </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.25,0.72,0.5,0.39,0.5,0.28,0.78,0.5,0.33,0.44,0.25,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.67,0.44,0.44,0.44,0.5,0.28,0.25,0.39,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.5,0.44,0.5,0.44,0.25" y="413.5" x="70.9,76.9,82.9,88.9,94.9,98.3,101.1,109.8,115.8,120.5,126.5,129.8,139.2,145.2,149.2,154.5,157.5,160.4,166.4,172.4,178.4,184.4,188.4,191.4,194.3,202.3,207.6,212.9,218.3,224.3,227.6,230.5,235.1,238.5,244.4,250.4,253.8,259.1,263.8,266.6,272.6,278.0,283.9,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2000; Yoshimura, 2006). Recent studies have </text>
  <text svgx:width="0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.44,0.28,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.25,0.55,0.5,0.33,0.25" y="427.3" x="70.9,74.9,80.3,86.3,92.3,96.3,99.6,105.0,111.0,114.0,115.2,118.5,124.5,129.8,133.2,136.2,137.4,140.7,146.7,152.1,155.1,156.3,161.6,167.6,170.9,174.2,178.2,181.6,187.5,191.5,194.8,200.2,209.5,218.9,224.2,227.6,233.6,237.6,243.6,246.6,247.8,253.1,257.1,261.0,266.4,271.7,275.1,278.1,279.3,285.3,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">reported that the anti-inflammatory effect of </text>
  <text svgx:width="0.5,0.5,0.5,0.28,0.5,0.44,0.5,0.44,0.78,0.28,0.44,0.44,0.28,0.39,0.25,0.55,0.5,0.44,0.44,0.5,0.33,0.39,0.25,0.55,0.28,0.5,0.33,0.5,0.5,0.5,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.5,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25" y="441.1" x="70.9,76.9,82.9,88.9,92.3,98.3,103.6,109.6,114.9,124.2,127.5,132.9,138.2,141.5,146.2,149.2,151.8,157.8,163.1,168.5,174.5,178.5,183.1,186.1,188.7,192.0,198.0,202.0,208.0,214.0,220.0,226.0,229.0,231.6,237.6,241.0,247.0,252.3,258.3,261.6,267.6,273.6,276.6,279.2,285.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">phytochemicals occurs through blocking of </text>
  <text svgx:width="0.28,0.5,0.44,0.25,0.55,0.72,0.56,0.33,0.5,0.67,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.44,0.28,0.5,0.72,0.44,0.5,0.25,0.55,0.33,0.72,0.44,0.78,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25" y="454.9" x="70.9,74.3,80.3,85.6,88.6,91.4,100.1,106.8,110.8,116.8,124.8,127.8,130.6,135.3,138.6,144.6,150.6,156.0,159.3,162.6,168.6,174.6,177.6,180.5,186.5,191.8,195.1,201.1,209.8,215.1,221.1,224.1,226.9,230.9,239.6,244.9,254.2,257.2,260.1,265.4,268.7,271.7,274.5,279.9,283.2,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">the NF-κB signaling pathway (Ham et al., </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.72,0.39,0.28,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.89,0.28,0.28,0.5,0.5,0.44,0.5,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.44,0.5,0.25" y="468.7" x="70.9,76.9,82.9,88.9,94.9,98.2,101.2,102.4,111.0,115.7,119.0,124.4,130.4,133.4,134.5,139.8,143.2,146.2,147.3,152.6,156.0,159.0,162.0,165.0,166.1,172.1,178.1,184.1,190.1,194.1,197.1,200.1,201.2,211.9,215.2,218.6,224.6,230.6,235.9,241.9,245.9,251.2,256.5,259.9,263.2,269.2,274.5,277.8,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2015; Hsieh et al., 2011). Mitogen-activated </text>
  <text svgx:width="0.5,0.33,0.5,0.28,0.44,0.28,0.5,0.25,0.5,0.28,0.5,0.44,0.39,0.44,0.39,0.25,0.33,0.89,0.72,0.56,0.72,0.39,0.33,0.25,0.44,0.33,0.44,0.25,0.5,0.5,0.44,0.25,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.78,0.44,0.28,0.5,0.33,0.25" y="482.5" x="70.9,76.9,80.9,86.9,90.3,95.6,98.9,105.0,107.4,113.4,116.7,122.7,128.0,132.7,138.0,142.7,145.1,149.1,159.8,168.5,175.2,183.8,188.5,192.5,194.9,200.2,204.2,209.6,212.0,218.0,224.0,229.3,231.7,237.7,241.7,244.1,247.5,253.5,258.8,261.2,270.5,275.8,279.2,285.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">protein kinases (MAPKs) are one of the major </text>
  <text svgx:width="0.5,0.28,0.5,0.44,0.39,0.44,0.39,0.25,0.28,0.5,0.5,0.5,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.44,0.33,0.25,0.5,0.33,0.5,0.44,0.44,0.39,0.39,0.44,0.39,0.25,0.39,0.5,0.44,0.5,0.25,0.44,0.39,0.25" y="496.3" x="70.9,76.9,80.3,86.3,91.6,96.3,101.7,106.3,109.3,112.6,118.6,124.6,130.6,133.9,139.9,145.3,151.3,154.2,157.6,163.6,166.5,171.8,177.1,180.5,183.8,189.8,193.1,198.5,202.5,205.4,211.4,215.4,221.4,226.7,232.0,236.7,241.3,246.6,251.3,254.2,258.9,264.9,270.3,276.3,279.2,284.5,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">kinases involved in cellular processes such as </text>
  <text svgx:width="0.44,0.5,0.5,0.5,0.28,0.5,0.39,0.28,0.39,0.25,0.25,0.55,0.39,0.28,0.33,0.44,0.39,0.39,0.25,0.55,0.33,0.44,0.39,0.5,0.5,0.5,0.39,0.44,0.39,0.25,0.25,0.55,0.5,0.28,0.33,0.33,0.44,0.33,0.44,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25,0.25" y="510.1" x="70.9,76.3,82.3,88.3,94.3,97.6,103.6,108.3,111.6,116.3,119.3,122.3,126.6,131.2,134.6,138.6,143.9,148.6,153.3,156.3,160.5,164.5,169.9,174.5,180.5,186.5,192.6,197.2,202.6,207.2,210.2,213.2,217.5,223.5,226.9,230.9,234.9,240.2,244.2,249.5,255.5,258.9,262.2,267.5,270.9,274.2,280.2,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">apoptosis, stress responses, differentiation, </text>
  <text svgx:width="0.44,0.5,0.5,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.44,0.25,0.55,0.5,0.44,0.33,0.44,0.5,0.39,0.44,0.25,0.55,0.33,0.61,0.28,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25" y="523.9" x="70.9,76.3,82.3,88.3,91.3,96.6,99.9,109.3,118.5,124.5,130.5,135.8,138.8,144.2,150.2,155.5,159.5,164.8,170.8,175.5,180.8,183.8,189.2,193.2,200.5,203.8,209.8,212.8,218.2,223.5,226.8,229.8,235.2,240.5,243.8,246.9,249.9,252.9,258.2,264.2,270.2,276.2,282.2,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and immune defense (Liu et al., 2007). </text>
  <text svgx:width="0.89,0.72,0.56,0.72,0.39,0.25,0.55,0.44,0.5,0.78,0.5,0.33,0.28,0.39,0.44,0.25,0.55,0.28,0.5,0.33,0.44,0.44,0.25,0.55,0.78,0.44,0.28,0.5,0.33,0.25,0.55,0.39,0.5,0.5,0.5,0.33,0.5,0.5,0.5,0.39,0.25,0.25" y="537.7" x="70.9,81.6,90.3,96.9,105.6,110.3,113.3,117.9,123.3,129.3,138.6,144.6,148.6,152.0,156.6,162.0,165.0,169.6,173.0,179.0,183.0,188.3,193.6,196.6,201.3,210.5,215.9,219.2,225.2,229.2,232.2,236.9,241.6,247.6,253.6,259.6,263.6,269.6,275.6,281.6,286.3,289.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">MAPKs comprise three major subgroups, </text>
  <text svgx:width="0.5,0.44,0.78,0.44,0.28,0.5,0.25,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.89,0.72,0.56,0.72,0.39,0.25,0.25,0.55,0.44,0.33,0.39,0.5,0.5,0.25,0.55,0.72,0.33,0.28,0.44,0.33,0.78,0.28,0.5,0.44,0.28,0.25,0.55,0.5,0.28,0.33" y="551.5" x="70.9,76.9,82.3,91.5,96.8,100.2,106.2,109.2,112.2,114.7,120.7,126.7,132.7,135.7,138.3,148.9,157.6,164.3,172.9,177.6,180.6,183.6,186.1,191.5,195.5,200.1,206.1,212.1,215.1,217.7,226.3,230.3,233.7,239.0,243.0,252.2,255.6,261.6,266.9,270.3,273.3,275.8,281.8,285.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">namely, p38 MAPKs, c-Jun N-terminal ki-</text>
  <text svgx:width="0.5,0.44,0.39,0.44,0.39,0.25,0.55,0.33,0.39,0.72,0.72,0.39,0.33,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.33,0.44,0.44,0.44,0.28,0.28,0.5,0.28,0.44,0.33,0.25,0.55,0.39,0.28,0.5,0.5,0.44,0.28,0.33,0.33,0.44,0.5,0.5,0.33" y="565.3" x="70.9,76.9,82.3,86.9,92.3,96.9,99.9,101.8,105.8,110.4,119.1,127.8,132.5,136.5,139.5,142.5,144.3,149.6,155.6,161.6,164.6,166.4,171.8,177.8,181.1,185.1,190.4,195.8,201.1,204.4,207.8,213.8,217.1,222.4,226.4,229.4,231.3,235.9,239.3,245.2,251.2,256.5,259.9,263.9,267.9,273.2,279.2,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">nases (JNKs), and extracellular signal-regu-</text>
  <text svgx:width="0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.28,0.5,0.44,0.39,0.44,0.39,0.25,0.55,0.33,0.61,0.67,0.72,0.39,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.28,0.33,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.55,0.5,0.28,0.44,0.5,0.39,0.25" y="579.1" x="70.9,74.3,79.6,82.9,88.3,94.3,97.3,98.5,104.5,107.9,113.9,119.2,123.9,129.2,133.9,136.9,138.1,142.1,149.4,157.4,166.1,170.8,174.8,177.8,180.8,182.0,189.4,195.4,200.7,204.0,208.0,211.0,212.3,217.6,223.0,226.3,229.6,235.6,241.0,244.3,247.6,253.6,259.6,262.6,263.9,269.9,273.2,278.6,284.6,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">lated kinases (ERKs). Their activation plays </text>
  <text svgx:width="0.44,0.5,0.25,0.55,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.55,0.33,0.5,0.28,0.44,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.5,0.33,0.44,0.39,0.39,0.28,0.5,0.5,0.25,0.55,0.5,0.33,0.25,0.55,0.28,0.72,0.72,0.56,0.25" y="592.9" x="70.9,76.3,82.3,85.3,86.4,89.7,99.0,105.0,111.0,115.0,118.3,123.7,129.7,133.0,136.0,137.1,141.1,147.1,150.5,155.8,158.8,159.9,163.3,169.3,172.3,173.4,176.7,182.8,188.1,191.1,192.2,197.5,203.5,209.6,213.6,218.9,223.6,228.2,231.6,237.6,243.6,246.6,247.7,253.7,257.7,260.7,261.8,265.2,273.9,282.5,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">an important role in the expression of iNOS </text>
  <text svgx:width="0.44,0.5,0.5,0.25,0.67,0.72,0.72,0.33,0.5,0.25,0.44,0.5,0.5,0.25,0.28,0.5,0.25,0.28,0.5,0.44,0.25,0.5,0.33,0.5,0.5,0.5,0.44,0.28,0.28,0.5,0.5,0.25,0.5,0.33,0.25,0.44,0.5,0.28,0.5,0.5,0.28,0.5,0.44,0.39,0.25" y="606.7" x="70.9,76.3,82.3,88.3,90.6,98.6,107.3,115.9,119.9,125.9,128.2,133.6,139.6,145.6,147.9,151.2,157.2,159.6,162.9,168.9,174.2,176.6,182.6,186.6,192.6,198.6,204.6,209.9,213.2,216.6,222.6,228.6,230.9,236.9,240.9,243.2,248.5,254.5,257.9,263.9,269.9,273.2,279.2,284.5,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and COX-2 and in the production of cytokines </text>
  <text svgx:width="0.33,0.67,0.44,0.28,0.44,0.5,0.44,0.5,0.39,0.44,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.67,0.44,0.5,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.33,0.44,0.33" y="620.5" x="70.9,74.9,82.9,88.2,91.6,96.9,102.9,108.2,114.2,118.9,124.2,127.2,129.0,134.4,137.7,140.7,142.5,147.9,151.2,154.2,157.2,160.2,162.0,168.0,174.0,180.0,186.0,189.3,192.3,194.2,202.2,207.5,213.5,216.5,219.5,221.4,227.4,233.3,239.3,245.3,249.3,252.3,255.3,257.2,264.5,270.5,275.8,279.8,285.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(Rajapakse et al., 2008; Rao, 2001). There-</text>
  <text svgx:width="0.33,0.5,0.33,0.44,0.25,0.25,0.89,0.72,0.56,0.72,0.25,0.44,0.5,0.5,0.25,0.72,0.56,0.33,0.5,0.67,0.25,0.78,0.44,0.5,0.25,0.5,0.44,0.25,0.44,0.33,0.33,0.44,0.44,0.28,0.28,0.5,0.44,0.25,0.44,0.39,0.25" y="634.3" x="70.9,74.9,80.9,84.9,90.2,93.2,97.0,107.7,116.3,123.0,131.7,135.5,140.8,146.8,152.8,156.6,165.2,171.9,175.9,182.0,190.0,193.8,203.0,208.4,214.4,218.2,224.2,229.6,233.3,238.7,242.7,246.7,252.1,257.4,260.8,264.1,270.1,275.4,279.2,284.5,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">fore, MAPK and NF-κB may be effective as </text>
  <text svgx:width="0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.5,0.44,0.5,0.28,0.39,0.25,0.25" y="648.1" x="70.9,76.3,82.3,85.6,88.9,92.9,96.3,102.3,106.3,109.6,115.0,124.3,133.5,138.9,142.2,148.2,152.2,158.2,161.2,166.6,172.6,177.9,183.9,187.2,191.9,194.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">anti-inflammatory agents. </text>
  <text svgx:width="0.56,0.28,0.5,0.5,0.44,0.39,0.5,0.25,0.55,0.44,0.39,0.44,0.28,0.5,0.39,0.5,0.44,0.5,0.39,0.5,0.5" y="661.9" x="88.8,95.5,98.8,104.8,110.8,116.2,120.8,126.8,129.8,132.8,138.1,142.8,148.1,151.5,157.5,162.1,168.1,173.5,179.5,184.2,190.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lindera erythrocarpa</text>
  <text svgx:width="0.25,0.55,0.28,0.39,0.25,0.55,0.72,0.28,0.5,0.44,0.28,0.5,0.25,0.55,0.5,0.28,0.39,0.28,0.33,0.28,0.5,0.33" y="661.9" x="196.1,199.1,202.1,205.4,210.1,213.1,216.0,224.6,228.0,234.0,239.3,242.6,248.6,251.6,254.5,260.5,263.9,268.5,271.9,275.9,279.2,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> is widely distrib-</text>
  <text svgx:width="0.5,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.67,0.44,0.5,0.5,0.5,0.28,0.28,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.72,0.5,0.33,0.44,0.44,0.25,0.25,0.55,0.39,0.44,0.5,0.44,0.5,0.25,0.25,0.55,0.44,0.5,0.5,0.25" y="675.7" x="70.9,76.9,80.3,85.6,91.6,94.6,97.3,100.7,106.7,109.7,112.4,115.8,121.8,127.1,130.1,132.8,140.9,146.2,152.2,158.2,164.2,167.5,170.9,176.2,179.2,181.9,187.9,191.9,194.9,197.7,206.4,212.4,216.4,221.7,227.0,230.0,233.0,235.8,240.4,245.8,251.8,257.1,263.1,266.1,269.1,271.8,277.2,283.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">uted in the Republic of Korea, Japan, and </text>
  <text svgx:width="0.67,0.5,0.28,0.5,0.44,0.25,0.55,0.33,0.56,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.5,0.5,0.5,0.5,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25" y="689.5" x="70.9,78.9,84.9,88.3,94.3,99.6,102.6,103.9,107.9,114.5,120.5,126.5,129.5,130.8,136.1,142.1,148.1,151.1,152.4,160.4,166.4,172.4,178.4,184.4,187.4,190.4,191.7,197.7,203.7,209.7,215.7,219.7,222.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">China (Sun and Chung, 1988). </text>
  <text svgx:width="0.56,0.28,0.5,0.5,0.44,0.39,0.5" y="689.5" x="226.9,233.6,236.9,242.9,248.9,254.2,258.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Lindera</text>
  <text svgx:width="0.25,0.55,0.39,0.5,0.44,0.33" y="689.5" x="264.9,267.9,269.2,273.8,279.8,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> spe-</text>
  <text svgx:width="0.44,0.28,0.44,0.39,0.25,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5,0.28,0.5,0.5,0.25" y="703.3" x="70.9,76.2,79.6,84.9,89.6,92.6,95.6,96.8,100.2,106.2,111.5,114.8,120.8,126.8,130.2,136.2,142.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">cies, including </text>
  <text svgx:width="0.56,0.25,0.25,0.55,0.39,0.28,0.39,0.44,0.44,0.5,0.5,0.28,0.28,0.5,0.28,0.28,0.5" y="703.3" x="146.4,153.1,156.1,159.1,160.3,165.0,168.4,173.0,178.4,183.7,189.7,195.7,199.0,202.4,208.4,211.7,215.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">L. strychnifolia</text>
  <text svgx:width="0.25" y="703.3" x="221.0" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.25,0.55,0.56,0.25,0.25,0.55,0.28,0.5,0.44,0.28,0.5,0.5" y="703.3" x="224.0,227.0,228.3,235.0,238.0,241.0,242.2,245.6,251.6,256.9,260.2,266.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> L. lucida</text>
  <text svgx:width="0.25" y="703.3" x="272.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">,</text>
  <text svgx:width="0.25,0.55,0.56,0.25,0.25" y="703.3" x="275.2,278.2,279.5,286.1,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> L. </text>
  <text svgx:width="0.44,0.5,0.5,0.5,0.28,0.28" y="717.1" x="70.9,76.3,82.3,88.3,94.3,97.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">chunii</text>
  <text svgx:width="0.25,0.25,0.44,0.5,0.5,0.25" y="717.1" x="101.0,104.0,106.5,111.8,117.8,123.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">, and </text>
  <text svgx:width="0.56,0.25,0.25,0.5,0.5,0.5,0.39,0.44,0.5,0.5,0.28,0.44" y="717.1" x="126.2,132.9,135.9,138.4,144.4,150.4,156.5,161.1,166.5,172.5,178.5,181.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">L. aggregate</text>
  <text svgx:width="0.25,0.44,0.33,0.44,0.25,0.28,0.78,0.5,0.5,0.33,0.28,0.44,0.5,0.28,0.25,0.78,0.44,0.5,0.28,0.44,0.33" y="717.1" x="187.1,189.6,194.9,198.9,204.3,206.8,210.1,219.4,225.4,231.4,235.4,238.7,244.0,250.0,253.4,255.9,265.1,270.5,276.5,279.8,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> are important medic-</text>
  <text svgx:width="0.28,0.5,0.44,0.28,0.25,0.5,0.28,0.44,0.5,0.28,0.39,0.25,0.25,0.61,0.5,0.44,0.25,0.33,0.33,0.5,0.28,0.28,0.25,0.44,0.5,0.5,0.25,0.28,0.44,0.44,0.5,0.44,0.39,0.25,0.5,0.33,0.25" y="730.9" x="70.9,74.3,80.3,85.6,88.9,91.8,97.8,101.1,106.5,112.5,115.8,120.5,123.5,126.4,133.7,139.7,145.0,147.9,151.9,155.9,161.9,165.3,168.6,171.5,176.8,182.8,188.8,191.6,195.0,200.3,205.6,211.7,217.0,221.6,224.5,230.5,234.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">inal plants. The fruit and leaves of </text>
  <text svgx:width="0.56,0.25,0.25,0.44,0.39,0.44,0.28,0.5,0.39,0.5,0.33" y="730.9" x="237.3,244.0,247.0,249.9,255.2,259.9,265.2,268.6,274.6,279.2,285.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">L. erythro-</text>
  <text svgx:width="0.44,0.5,0.39,0.5,0.5" y="744.7" x="70.9,76.3,82.3,86.9,92.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">carpa</text>
  <text svgx:width="0.25,0.55,0.44,0.33,0.44,0.25,0.55,0.5,0.39,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.33,0.5,0.28,0.5,0.25,0.55,0.78,0.44,0.5,0.28,0.44,0.28,0.5,0.44,0.25,0.55,0.33,0.5,0.33,0.25,0.55,0.28,0.33,0.44,0.44,0.28,0.28,0.5,0.5,0.25" y="744.7" x="98.9,101.9,103.3,108.6,112.6,118.0,121.0,122.3,128.2,132.9,138.2,144.3,147.3,148.6,151.9,157.9,160.9,162.3,166.2,172.2,175.6,181.6,184.6,185.9,195.2,200.5,206.5,209.9,215.2,218.6,224.6,229.9,232.9,234.2,238.2,244.3,248.3,251.3,252.6,255.9,260.0,265.2,270.6,273.9,277.3,283.3,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> are used in folk medicine for treating </text>
  <text svgx:width="0.5,0.28,0.5,0.44,0.39,0.28,0.28,0.5,0.44,0.25,0.5,0.28,0.39,0.5,0.33,0.5,0.44,0.33,0.39,0.25,0.25,0.28,0.5,0.28,0.33,0.39,0.28,0.25,0.25,0.5,0.44,0.28,0.5,0.25,0.25,0.44,0.5,0.5,0.25,0.5,0.44,0.5,0.33,0.44,0.28,0.5,0.28,0.44,0.25,0.25" y="758.5" x="70.9,76.9,80.3,86.3,91.6,96.3,99.6,102.9,108.9,114.3,116.6,122.6,125.9,130.6,136.6,140.6,146.6,151.9,155.9,160.6,163.6,165.9,169.2,175.2,178.6,182.6,187.2,190.6,193.6,195.9,201.9,207.2,210.6,216.6,219.6,221.9,227.2,233.2,239.2,241.6,247.6,252.9,258.9,262.9,268.2,271.5,277.5,280.9,286.2,289.2" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">digestive disorders, thirst, pain, and neuralgia. </text>
  <text svgx:width="0.61,0.5,0.44,0.5,0.25,0.44,0.33,0.44,0.25,0.44,0.28,0.39,0.5,0.25,0.5,0.39,0.44,0.5,0.25,0.44,0.39,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.28,0.44,0.39,0.25,0.44,0.5,0.5,0.25,0.5,0.28,0.5,0.33,0.44,0.28,0.28,0.44,0.39,0.25" y="96.1" x="306.1,313.5,319.5,324.8,330.8,334.5,339.8,343.8,349.1,352.8,358.1,361.5,366.1,372.1,375.7,381.7,386.4,391.7,397.8,401.4,406.7,411.4,415.1,420.4,426.3,429.7,433.0,439.0,445.0,448.4,453.7,458.4,462.0,467.4,473.4,479.4,483.0,489.1,492.4,498.4,502.4,507.7,511.1,514.4,519.8,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">They are also used as antidotes and diuretics </text>
  <text svgx:width="0.33,0.72,0.5,0.5,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.72,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.56,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25" y="109.9" x="306.1,310.1,318.8,324.8,330.8,336.8,339.8,340.7,346.1,349.4,352.4,353.4,358.7,362.0,365.0,368.0,371.0,372.0,378.0,384.0,390.0,396.0,399.3,402.3,403.3,411.9,417.9,420.9,421.9,427.2,430.5,433.5,434.5,439.8,443.2,446.2,449.2,452.2,453.1,459.1,465.1,471.1,477.1,480.5,483.5,484.4,491.1,497.1,503.1,506.1,507.0,512.4,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(Hong et al., 2009; Oh et al., 2005; Sun and </text>
  <text svgx:width="0.67,0.5,0.5,0.5,0.5,0.25,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.67,0.44,0.44,0.44,0.5,0.28,0.28,0.5,0.25,0.25" y="123.7" x="306.1,314.1,320.1,326.1,332.1,338.1,341.1,344.1,350.1,356.1,362.1,368.1,372.1,375.1,378.1,386.1,391.5,396.8,402.1,408.1,411.4,414.8,420.7,423.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Chung, 1988). Recently, </text>
  <text svgx:width="0.56,0.25,0.25,0.44,0.39,0.44,0.28,0.5,0.39,0.5,0.44,0.5,0.39,0.5,0.5" y="123.7" x="426.7,433.4,436.4,439.4,444.7,449.4,454.7,458.0,464.0,468.7,474.7,480.0,486.0,490.7,496.7" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">L. erythrocarpa</text>
  <text svgx:width="0.25,0.72,0.44,0.39,0.25" y="123.7" x="502.7,505.7,514.3,519.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> was </text>
  <text svgx:width="0.33,0.44,0.5,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.28,0.5,0.25,0.55,0.39,0.5,0.5,0.5,0.33,0.44,0.39,0.39,0.25,0.55,0.44,0.5,0.28,0.5,0.5,0.5,0.44,0.5,0.44,0.39,0.28,0.39,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.78,0.44,0.28,0.44,0.33" y="137.5" x="306.1,310.1,315.5,321.5,327.5,331.5,334.8,340.1,346.1,349.1,350.3,353.6,359.7,362.7,363.8,368.5,374.5,380.5,386.5,390.5,395.8,400.5,405.2,408.2,409.4,414.7,420.7,424.0,430.0,436.0,442.0,447.4,453.4,458.7,463.4,466.7,471.4,474.4,475.6,480.9,486.9,492.9,495.9,497.1,506.3,511.7,515.0,520.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">reported to suppress adipogenesis and mela-</text>
  <text svgx:width="0.5,0.28,0.5,0.25,0.39,0.5,0.5,0.28,0.5,0.44,0.39,0.28,0.39,0.25,0.25,0.44,0.28,0.28,0.44,0.5,0.5,0.44,0.28,0.44,0.25,0.5,0.5,0.44,0.39,0.28,0.28,0.5,0.25,0.25,0.44,0.39,0.25,0.72,0.44,0.28,0.28,0.25,0.44,0.39,0.25,0.44,0.5,0.33" y="151.3" x="306.1,312.1,315.5,321.5,324.2,328.8,334.8,340.9,344.2,350.2,355.5,360.2,363.6,368.2,371.2,373.9,379.3,382.6,385.9,391.3,397.3,403.3,408.6,412.0,417.3,420.0,426.0,432.0,437.3,442.0,445.3,448.7,454.7,457.7,460.4,465.7,470.4,473.1,481.8,487.1,490.4,493.8,496.5,501.8,506.5,509.2,514.5,520.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">nin synthesis, attenuate obesity, as well as ex-</text>
  <text svgx:width="0.5,0.28,0.5,0.28,0.28,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.5,0.28,0.25,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.33" y="165.1" x="306.1,312.1,315.5,321.5,324.8,328.1,331.1,332.2,337.5,343.5,346.9,350.2,356.2,362.2,365.6,371.6,376.9,382.9,386.2,389.2,392.2,393.3,398.6,404.6,408.0,411.3,415.3,418.6,424.6,428.6,432.0,437.3,446.7,456.0,461.3,464.7,470.7,474.7,480.7,483.7,486.7,487.7,493.1,499.1,505.1,508.1,509.1,514.5,520.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">hibit antioxidant, anti-inflammatory, and an-</text>
  <text svgx:width="0.28,0.28,0.33,0.5,0.5,0.5,0.44,0.28,0.25,0.55,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.28,0.44,0.39,0.25,0.55,0.33,0.72,0.39,0.28,0.44,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.94,0.44,0.5,0.5,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.25" y="178.9" x="306.1,309.5,312.8,316.8,322.8,328.8,334.8,340.1,343.5,346.5,349.3,354.7,360.0,363.4,366.7,372.7,376.0,379.4,382.7,388.0,392.7,395.7,398.6,402.6,411.3,415.9,419.3,424.6,430.6,433.6,436.5,441.8,447.8,453.8,456.8,459.7,470.9,476.2,482.2,488.2,491.2,494.2,497.1,503.1,509.1,515.1,521.1,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">tifungal activities (Hsieh and Wang, 2013; </text>
  <text svgx:width="0.72,0.72,0.44,0.5,0.5,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.25,0.72,0.5,0.78,0.44,0.33,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.25,0.94,0.44,0.5,0.5,0.25" y="192.7" x="306.1,314.8,323.5,328.8,334.8,340.8,343.3,348.7,352.0,354.5,359.9,363.2,366.2,369.2,371.7,377.7,383.7,389.7,395.8,399.1,401.6,410.3,416.3,425.6,431.0,435.0,437.5,442.8,446.1,448.7,454.0,457.4,460.4,463.4,465.9,471.9,477.9,483.9,489.9,493.3,495.8,507.0,512.4,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Hwang et al., 2007; Kumar et al., 2010; Wang </text>
  <text svgx:width="0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.61,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.39,0.25,0.44,0.5,0.28,0.33,0.44,0.44,0.28,0.44,0.5,0.25,0.33,0.33,0.5,0.78,0.25,0.78,0.44,0.33" y="206.5" x="306.1,311.5,314.8,317.3,322.6,325.9,328.9,331.9,334.4,340.4,346.4,352.4,358.4,362.4,365.4,367.9,375.2,379.9,384.6,389.9,395.9,399.2,402.6,407.9,411.2,413.7,419.7,423.0,426.4,431.1,433.5,438.9,444.9,448.2,452.2,457.5,462.9,466.2,471.5,477.5,480.0,484.0,488.0,494.0,503.2,505.7,515.0,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">et al., 2008). Essential oils extracted from me-</text>
  <text svgx:width="0.5,0.28,0.44,0.28,0.5,0.44,0.28,0.25,0.44,0.5,0.5,0.25,0.44,0.33,0.5,0.78,0.44,0.28,0.28,0.44,0.25,0.5,0.28,0.44,0.5,0.28,0.39,0.25,0.44,0.33,0.44,0.25,0.5,0.5,0.5,0.72,0.5,0.25,0.28,0.5,0.25,0.5,0.44,0.5,0.44,0.25" y="220.3" x="306.1,312.1,315.5,320.8,324.1,330.1,335.4,338.8,341.4,346.7,352.7,358.7,361.4,366.7,370.7,376.7,385.9,391.3,394.6,397.9,403.2,405.9,411.9,415.2,420.5,426.5,429.9,434.5,437.2,442.5,446.5,451.8,454.5,460.5,466.5,472.5,481.1,487.1,489.8,493.1,499.1,501.7,507.7,513.1,519.0,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">dicinal and aromatic plants are known to have </text>
  <text svgx:width="0.5,0.28,0.5,0.28,0.5,0.5,0.28,0.44,0.44,0.28,0.25,0.55,0.44,0.33,0.33,0.44,0.44,0.28,0.39,0.25,0.25,0.55,0.78,0.5,0.39,0.28,0.25,0.55,0.5,0.5,0.28,0.44,0.5,0.28,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.33" y="234.1" x="306.1,312.1,315.5,321.5,324.8,330.8,336.8,340.1,345.4,350.8,354.1,357.1,358.8,364.1,368.1,372.1,377.4,382.8,386.1,390.8,393.8,396.8,398.4,407.7,413.7,418.3,421.7,424.7,426.4,432.4,438.4,441.8,447.1,453.1,456.4,462.4,465.4,467.1,472.5,478.5,481.8,485.1,489.1,492.5,498.5,502.5,505.8,511.2,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">biological effects, most notably anti-inflam-</text>
  <text svgx:width="0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.5,0.28,0.5,0.44,0.5,0.28,0.25,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.5,0.5,0.5,0.44,0.28,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.5,0.44,0.44,0.33" y="247.9" x="306.1,315.4,320.7,324.0,330.0,334.0,340.0,343.1,346.1,347.2,352.5,358.5,361.9,365.2,371.2,377.2,380.6,386.6,391.9,397.9,401.2,404.2,407.2,408.4,413.7,419.7,423.0,426.4,430.4,436.4,442.4,448.4,453.7,457.1,460.1,463.1,464.2,469.5,475.5,481.6,484.6,485.7,491.0,497.0,500.4,503.7,509.7,515.0,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">matory, antioxidant, antifungal, and antibac-</text>
  <text svgx:width="0.28,0.44,0.33,0.28,0.44,0.28,0.25,0.44,0.44,0.28,0.28,0.5,0.28,0.28,0.28,0.44,0.39,0.25,0.33,0.67,0.5,0.44,0.28,0.44,0.5,0.25,0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.25,0.5,0.5,0.5,0.5,0.28,0.25,0.56,0.28,0.5,0.5,0.44,0.28,0.33,0.5,0.25" y="261.7" x="306.1,309.5,314.8,318.8,322.1,327.5,330.8,334.3,339.6,345.0,348.3,351.7,357.7,361.0,364.4,367.7,373.0,377.7,381.2,385.2,393.2,399.2,404.5,407.9,413.2,419.2,422.6,427.9,431.3,434.7,440.1,443.4,446.4,449.4,452.9,458.9,464.9,470.9,476.9,480.2,483.7,490.3,493.7,499.7,505.7,511.0,514.3,518.3,524.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">terial activities (Chaieb et al., 2007; Pinheiro </text>
  <text svgx:width="0.44,0.28,0.25,0.44,0.28,0.25,0.25,0.25,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.61,0.5,0.44,0.39,0.44,0.25,0.5,0.33,0.5,0.5,0.44,0.33,0.28,0.28,0.44,0.39,0.25,0.44,0.33,0.44,0.25,0.44,0.25,0.5,0.33,0.28,0.5,0.28,0.5,0.5,0.25,0.28,0.5,0.33" y="275.5" x="306.1,311.5,314.8,317.2,322.5,325.9,328.9,331.9,334.3,340.3,346.3,352.3,358.3,362.3,365.3,367.7,375.0,381.0,386.3,391.0,396.3,398.7,404.7,408.7,414.7,420.7,426.1,430.1,433.4,436.8,442.1,446.8,449.2,454.5,458.5,463.8,466.2,471.5,473.9,479.9,483.9,487.3,493.3,496.6,502.6,508.6,511.0,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">et al., 2011). These properties are a driving in-</text>
  <text svgx:width="0.28,0.44,0.33,0.44,0.39,0.28,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.5,0.39,0.44,0.25,0.55,0.5,0.33,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.28,0.28,0.44,0.28,0.25,0.55,0.5,0.28,0.28,0.39,0.25,0.55,0.28,0.5,0.25,0.55,0.28,0.5,0.44,0.25,0.55,0.44,0.5,0.39,0.33" y="289.3" x="306.1,309.5,314.8,318.8,324.2,328.8,332.2,335.2,336.5,339.9,345.9,348.9,350.3,353.6,359.6,364.9,367.9,369.3,375.3,380.0,385.3,388.3,389.7,395.7,399.7,402.7,404.1,409.4,414.1,418.8,424.1,430.1,433.5,436.8,442.1,445.5,448.5,449.8,455.8,459.2,462.5,467.2,470.2,471.6,475.0,481.0,484.0,485.3,488.7,494.7,500.1,503.1,504.4,509.8,515.8,520.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">terest in the use of essential oils in the cos-</text>
  <text svgx:width="0.78,0.44,0.28,0.28,0.44,0.25,0.25,0.55,0.5,0.5,0.44,0.33,0.78,0.44,0.44,0.44,0.5,0.28,0.28,0.44,0.44,0.28,0.25,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.5,0.5,0.5,0.25,0.55,0.28,0.5,0.5,0.5,0.39,0.28,0.33,0.28,0.44,0.39,0.25" y="303.1" x="306.1,315.4,320.7,324.0,327.4,332.7,335.7,338.7,342.3,348.3,354.3,359.7,363.7,372.9,378.2,383.6,388.9,394.9,398.3,401.6,406.9,412.3,415.6,418.5,421.5,425.1,430.5,436.5,442.5,445.5,449.1,453.1,459.1,465.1,471.1,474.1,477.7,481.0,487.0,493.0,499.0,503.7,507.0,511.0,514.4,519.7,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">metic, pharmaceutical, and food industries </text>
  <text svgx:width="0.33,0.67,0.5,0.44,0.28,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.61,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.67,0.5,0.44,0.5,0.5,0.44,0.5,0.44,0.33,0.25,0.25" y="316.9" x="306.1,310.1,318.1,324.1,329.5,332.8,338.1,344.1,347.1,349.6,354.9,358.2,361.2,363.7,369.0,372.4,375.4,378.4,381.4,383.8,389.8,395.8,401.8,407.8,411.1,414.1,416.6,423.9,429.2,435.2,441.2,444.2,446.7,452.0,458.0,464.0,467.0,469.4,477.4,483.4,488.8,494.8,500.8,506.1,512.1,517.4,521.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(Chaieb et al., 2007; Lang and Buchbauer, </text>
  <text svgx:width="0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.61,0.5,0.78,0.44,0.5,0.25,0.55,0.44,0.28,0.25,0.55,0.44,0.28,0.25,0.25,0.25,0.55,0.5,0.5,0.5,0.5,0.33,0.25,0.25,0.55,0.72,0.5,0.72,0.44,0.5,0.44,0.33,0.25,0.25,0.55,0.28,0.5,0.44,0.25" y="330.7" x="306.1,312.1,318.1,324.1,330.1,333.5,336.5,340.3,347.6,353.6,363.0,368.3,374.3,377.3,381.1,386.5,389.8,392.8,396.6,401.9,405.3,408.3,411.3,414.3,418.1,424.1,430.1,436.1,442.1,446.1,449.1,452.1,455.9,464.6,470.6,479.3,484.6,490.6,495.9,499.9,502.9,505.9,509.8,513.1,519.1,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2012; Tumen et al., 2010). However, the </text>
  <text svgx:width="0.78,0.44,0.44,0.5,0.44,0.5,0.28,0.39,0.78,0.25,0.5,0.5,0.25,0.72,0.5,0.28,0.44,0.5,0.25" y="344.5" x="306.1,315.4,320.7,326.0,332.0,337.4,343.4,346.7,351.4,360.7,364.5,370.5,376.5,380.4,389.1,395.1,398.4,403.8,409.8" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">mechanism by which </text>
  <text svgx:width="0.56,0.25,0.25,0.44,0.39,0.44,0.28,0.5,0.39,0.5,0.44,0.5,0.39,0.5,0.5,0.25" y="344.5" x="413.6,420.3,423.3,427.2,432.5,437.2,442.5,445.8,451.9,456.5,462.5,467.9,473.9,478.5,484.6,490.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-ItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">L. erythrocarpa </text>
  <text svgx:width="0.44,0.39,0.39,0.44,0.5,0.33" y="344.5" x="494.4,499.7,504.4,509.1,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">essen-</text>
  <text svgx:width="0.28,0.28,0.44,0.28,0.25,0.5,0.28,0.28,0.25,0.33,0.61,0.61,0.72,0.33,0.25,0.44,0.5,0.44,0.33,0.28,0.39,0.25,0.28,0.28,0.39,0.25,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.33,0.33" y="358.3" x="306.1,309.5,312.8,318.1,321.5,324.5,330.5,333.9,337.2,340.3,344.3,351.6,358.9,367.5,371.6,374.6,380.0,386.0,391.3,395.3,398.7,403.4,406.4,409.8,413.1,417.7,420.8,426.1,432.2,435.5,438.9,442.9,446.2,452.2,456.2,459.5,464.9,474.1,483.4,488.7,492.1,498.1,502.1,508.1,511.2,516.5,520.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">tial oil (LEO) exerts its anti-inflammatory ef-</text>
  <text svgx:width="0.33,0.44,0.44,0.28,0.25,0.5,0.44,0.39,0.25,0.5,0.5,0.28,0.25,0.5,0.44,0.44,0.5,0.25,0.44,0.28,0.5,0.44,0.28,0.5,0.44,0.28,0.44,0.5,0.25,0.25,0.61,0.5,0.44,0.33,0.44,0.33,0.5,0.33,0.44,0.25,0.25,0.28,0.5,0.25,0.28,0.5,0.28,0.39,0.25" y="372.1" x="306.1,310.1,315.5,320.8,324.1,326.5,332.6,337.9,342.6,345.0,351.0,357.0,360.3,362.7,368.7,374.1,379.4,385.4,387.8,393.2,396.5,402.5,407.8,411.2,417.1,422.4,425.8,431.1,437.1,440.1,442.5,449.9,455.9,461.2,465.2,470.5,474.6,480.6,484.6,489.9,492.9,495.3,498.7,504.7,507.1,510.4,516.4,519.8,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">fect has not been elucidated. Therefore, in this </text>
  <text svgx:width="0.39,0.28,0.5,0.5,0.5,0.25,0.25,0.72,0.44,0.25,0.44,0.5,0.44,0.78,0.28,0.5,0.44,0.5,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.28,0.28,0.33,0.28,0.5,0.33,0.28,0.44,0.78,0.78,0.44,0.28,0.5,0.33,0.5,0.25,0.44,0.33,0.33" y="385.9" x="306.1,310.8,314.1,320.1,326.1,332.1,335.2,337.8,346.5,351.8,354.4,359.8,365.8,371.1,380.3,383.7,389.7,395.0,401.0,403.7,407.0,413.0,418.3,421.0,426.4,432.4,435.7,439.1,443.1,446.4,452.4,456.4,459.8,465.1,474.4,483.8,489.1,492.4,498.5,502.5,508.5,511.1,516.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">study, we examined the anti-inflammatory ef-</text>
  <text svgx:width="0.33,0.44,0.44,0.28,0.39,0.25,0.5,0.33,0.25,0.61,0.61,0.72,0.25,0.44,0.5,0.5,0.25,0.28,0.28,0.39,0.25,0.44,0.5,0.5,0.39,0.28,0.28,0.28,0.5,0.44,0.5,0.28,0.39,0.25,0.5,0.5,0.25,0.28,0.28,0.5,0.5,0.5,0.5,0.28,0.5,0.33" y="399.7" x="306.1,310.1,315.5,320.8,324.1,328.8,331.7,337.7,341.7,344.6,351.9,359.3,367.9,370.8,376.1,382.2,388.2,391.0,394.4,397.7,402.4,405.3,410.6,416.6,422.6,427.3,430.7,434.0,437.3,443.3,448.6,454.6,458.0,462.6,465.5,471.5,477.5,480.3,483.7,487.0,493.0,499.0,505.1,511.1,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">fects of LEO and its constituents on lipopoly-</text>
  <text svgx:width="0.39,0.44,0.44,0.44,0.5,0.44,0.33,0.28,0.5,0.44,0.25,0.55,0.33,0.61,0.56,0.56,0.33,0.33,0.39,0.28,0.28,0.78,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.67,0.72,0.94,0.5,0.5,0.5,0.25,0.5,0.25" y="413.5" x="306.1,310.8,316.1,321.4,326.8,332.8,338.1,342.1,345.4,351.4,356.7,359.7,371.7,375.7,383.0,389.7,396.4,400.4,404.4,409.0,412.4,415.7,425.0,431.0,434.4,439.7,443.0,448.4,454.4,457.4,469.3,477.3,486.0,497.3,503.3,509.3,515.3,518.3,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">saccharide (LPS)-stimulated RAW264.7 </text>
  <text svgx:width="0.44,0.44,0.28,0.28,0.39,0.25,0.25" y="427.3" x="306.1,311.5,316.8,320.1,323.5,328.1,331.1" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">cells. </text>
  <text svgx:width="0.94,0.72,0.67,0.67,0.72,0.39,0.72,0.67,0.56,0.25,0.72,0.72,0.72,0.25,0.94,0.67,0.67,0.78,0.78,0.72,0.56,0.25" y="455.0" x="332.2,343.5,352.2,360.2,368.2,376.8,381.6,390.3,398.3,404.9,407.9,416.6,425.2,433.9,436.9,448.3,456.3,464.3,473.6,482.9,491.6,498.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">MATERIALS AND METHODS </text>
  <text svgx:width="0.67,0.44,0.5,0.5,0.44,0.56,0.28,0.39,0.25" y="474.8" x="306.1,314.1,319.5,325.5,331.5,336.8,343.5,346.8,351.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPS-BoldItalicMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Reagents </text>
  <text svgx:width="0.61,0.56,0.56,0.25,0.25,0.5,0.5,0.5,0.39,0.5,0.5,0.44,0.28,0.44,0.25,0.5,0.5,0.33,0.33,0.44,0.33,0.44,0.5,0.25,0.39,0.44,0.28,0.28,0.5,0.44,0.25,0.33,0.56,0.67,0.56,0.33,0.25,0.25,0.5,0.28,0.33" y="488.5" x="324.0,331.3,338.0,344.7,347.7,350.4,356.4,362.4,368.4,373.1,379.1,385.1,390.4,393.8,399.1,401.8,407.8,413.8,417.8,421.8,427.2,431.1,436.5,442.5,445.2,449.9,455.2,458.6,461.9,467.9,473.2,476.0,480.0,486.6,494.6,501.3,505.3,508.3,511.1,517.1,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">LPS, phosphate buffered saline (PBS), di-</text>
  <text svgx:width="0.78,0.44,0.28,0.5,0.5,0.28,0.25,0.55,0.39,0.5,0.28,0.33,0.5,0.5,0.28,0.5,0.44,0.25,0.55,0.33,0.72,0.89,0.56,0.72,0.33,0.25,0.25,0.55,0.5,0.33,0.33,0.5,0.25,0.5,0.33,0.5,0.28,0.78,0.44,0.28,0.5,0.5,0.28,0.33" y="502.3" x="306.1,315.4,320.7,324.0,330.0,336.1,339.4,342.4,344.4,349.0,355.0,358.4,362.4,368.4,374.4,377.7,383.7,389.1,392.1,394.0,398.0,406.7,417.4,424.1,432.7,436.7,439.7,442.7,444.7,450.7,454.7,458.7,464.7,467.7,473.7,477.7,483.7,487.1,496.3,501.7,505.0,511.0,517.0,520.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">methyl sulfoxide (DMSO), 3-(4,5-dimethyl-</text>
  <text svgx:width="0.28,0.5,0.28,0.44,0.44,0.5,0.28,0.33,0.5,0.33,0.5,0.28,0.33,0.33,0.5,0.25,0.5,0.33,0.5,0.28,0.5,0.5,0.44,0.5,0.5,0.28,0.28,0.44,0.28,0.33,0.44,0.44,0.5,0.28,0.28,0.5,0.78,0.25,0.55,0.5,0.33,0.5,0.33" y="516.1" x="306.1,309.5,315.5,318.8,324.1,329.5,335.5,338.8,342.8,348.8,352.8,358.8,362.1,366.1,370.1,376.1,379.1,385.1,389.1,395.1,398.5,404.5,410.5,415.8,421.8,427.8,431.2,434.5,439.8,443.2,447.2,452.5,457.8,463.8,467.2,470.5,476.5,485.8,488.8,504.4,510.4,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">thiazol-2-yl)-2,5-diphenyltetrazolium bro-</text>
  <text svgx:width="0.78,0.28,0.5,0.44,0.25,0.55,0.33,0.89,0.61,0.61,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.33,0.44,0.5,0.28,0.5,0.33,0.28,0.78,0.78,0.5,0.5,0.5,0.5,0.33,0.44,0.44,0.28,0.5,0.28,0.28,0.44,0.28,0.28,0.5,0.5,0.25" y="529.9" x="306.1,315.4,318.7,324.7,330.1,333.1,334.8,338.8,349.5,356.8,364.1,368.1,371.1,372.9,378.2,384.2,390.2,393.2,395.0,399.0,404.3,410.3,413.6,419.6,423.6,427.0,436.3,445.7,451.7,457.7,463.7,469.7,473.7,479.0,484.3,487.7,493.7,497.0,500.4,505.7,509.0,512.4,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">mide (MTT) and radio-immunoprecipitation </text>
  <text svgx:width="0.44,0.39,0.39,0.44,0.5,0.25,0.55,0.67,0.33,0.56,0.72,0.25,0.55,0.28,0.5,0.39,0.28,0.39,0.25,0.55,0.5,0.5,0.33,0.33,0.44,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.5,0.5,0.5,0.28,0.25,0.55,0.33,0.33,0.5,0.78,0.25" y="543.7" x="306.1,311.5,316.1,320.8,326.1,332.1,335.1,337.7,345.7,349.7,356.4,365.1,368.1,370.6,374.0,380.0,384.6,388.0,392.7,395.7,398.2,404.2,410.2,414.2,418.2,423.6,427.6,430.6,433.2,441.9,447.2,451.2,456.5,459.5,462.1,468.1,474.1,480.1,486.1,492.1,495.5,498.5,501.0,505.0,509.0,515.0,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">assay RIPA lysis buffer were bought from </text>
  <text svgx:width="0.56,0.28,0.5,0.78,0.44,0.5,0.72,0.28,0.5,0.33,0.28,0.44,0.5,0.25,0.55,0.33,0.56,0.28,0.25,0.25,0.55,0.61,0.5,0.5,0.28,0.39,0.25,0.25,0.55,0.89,0.72,0.25,0.25,0.55,0.72,0.56,0.72,0.33,0.25,0.25,0.55,0.56,0.44,0.28,0.44,0.28,0.25" y="557.5" x="306.1,312.8,316.1,322.2,331.4,336.7,342.7,351.4,354.8,360.8,364.8,368.1,373.5,379.5,382.5,383.5,387.5,394.2,397.5,400.5,403.5,404.6,411.9,418.0,423.9,427.3,431.9,434.9,437.9,439.0,449.7,458.3,461.3,464.3,465.4,474.1,480.7,489.3,493.3,496.3,499.3,500.4,507.1,512.4,515.7,521.1,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Sigma–Aldrich (St. Louis, MO, USA). Fetal </text>
  <text svgx:width="0.5,0.5,0.5,0.28,0.5,0.44,0.25,0.39,0.44,0.33,0.5,0.78,0.25,0.33,0.56,0.67,0.56,0.33,0.25,0.44,0.5,0.5,0.25,0.72,0.5,0.28,0.5,0.44,0.44,0.44,0.5,0.33,0.39,0.25,0.78,0.5,0.5,0.28,0.33,0.28,0.44,0.5,0.25" y="571.3" x="306.1,312.1,318.1,324.1,327.5,333.5,338.8,341.1,345.8,351.2,355.2,361.1,370.3,372.7,376.7,383.3,391.4,398.0,402.0,404.4,409.7,415.7,421.7,424.0,432.7,438.7,442.1,448.1,453.4,458.7,464.1,470.1,474.1,478.7,481.1,490.4,496.4,502.4,505.8,509.8,513.1,518.5,524.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">bovine serum (FBS) and Dulbecco’s modified </text>
  <text svgx:width="0.61,0.44,0.5,0.28,0.44,0.33,0.39,0.25,0.55,0.78,0.44,0.5,0.28,0.5,0.78,0.25,0.55,0.33,0.72,0.89,0.61,0.89,0.33,0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.33,0.44,0.5,0.44,0.39,0.44,0.5,0.25" y="585.1" x="306.1,313.5,318.8,324.8,328.1,333.5,337.5,342.2,345.2,348.6,357.8,363.1,369.1,372.5,378.5,387.7,390.7,394.1,398.1,406.8,417.6,424.9,435.5,439.5,442.5,446.0,454.6,460.0,464.0,469.3,472.3,475.7,481.7,487.7,491.7,497.0,503.1,508.4,513.1,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">Eagle’s medium (DMEM) were purchased </text>
  <text svgx:width="0.33,0.33,0.5,0.78,0.25,0.55,0.33,0.5,0.5,0.28,0.28,0.33,0.5,0.5,0.44,0.5,0.33,0.72,0.28,0.5,0.44,0.5,0.25,0.55,0.33,0.72,0.33,0.44,0.5,0.5,0.25,0.55,0.33,0.39,0.28,0.44,0.5,0.5,0.25,0.25,0.55,0.72,0.72,0.25,0.25" y="598.9" x="306.1,310.1,314.1,320.1,329.4,332.4,335.6,339.6,345.6,351.6,355.0,358.3,362.3,368.3,374.3,379.6,385.6,389.7,398.3,401.7,407.7,413.0,419.0,422.0,425.2,429.2,437.9,441.9,447.2,453.2,459.3,462.3,465.5,469.5,474.2,477.5,482.8,488.8,494.9,497.9,500.9,504.1,512.8,521.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">from Invitrogen-Gibco (Grand Island, NY, </text>
  <text svgx:width="0.72,0.56,0.72,0.33,0.25,0.25,0.55,0.61,0.5,0.44,0.5,0.78,0.44,0.33,0.28,0.28,0.5,0.5,0.44,0.5,0.25,0.55,0.28,0.78,0.78,0.5,0.5,0.5,0.39,0.5,0.33,0.5,0.44,0.5,0.28,0.25,0.55,0.44,0.39,0.39,0.44,0.5,0.25" y="612.7" x="306.1,314.8,321.5,330.1,334.1,337.1,340.1,341.3,348.7,354.7,360.0,366.0,375.2,380.6,384.6,387.9,391.3,397.3,403.3,408.6,414.6,417.6,418.8,422.1,431.5,440.8,446.8,452.8,458.8,463.5,469.5,473.5,479.5,484.8,490.8,494.2,497.2,498.4,503.7,508.4,513.0,518.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">USA). Enzyme-linked immunosorbent assay </text>
  <text svgx:width="0.33,0.61,0.61,0.33,0.56,0.72,0.33,0.25,0.5,0.28,0.28,0.39,0.25,0.33,0.5,0.33,0.25,0.28,0.5,0.44,0.25,0.44,0.5,0.44,0.28,0.5,0.39,0.44,0.39,0.25,0.5,0.33,0.25,0.61,0.72,0.56,0.33,0.52,0.25,0.25,0.33,0.61,0.33,0.5,0.25,0.25" y="626.5" x="306.1,310.1,317.5,324.8,328.8,335.5,344.1,348.1,350.9,356.9,360.2,363.6,368.2,371.0,375.0,381.0,385.0,387.7,391.1,397.1,402.4,405.2,410.5,416.5,421.8,425.2,431.2,435.8,441.2,445.8,448.6,454.6,458.6,461.3,468.7,477.3,484.0,488.0,494.3,497.3,500.0,504.0,511.4,515.4,521.4,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">(ELISA) kits for the analyses of TNF-α, IL-6, </text>
  <text svgx:width="0.44,0.5,0.5,0.25,0.55,0.56,0.72,0.61" y="640.3" x="306.1,311.4,317.4,323.4,326.4,329.3,335.9,344.6" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">and PGE</text>
  <text svgx:width="0.5" y="640.7" x="351.9" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:8.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">2</text>
  <text svgx:width="0.25,0.55,0.72,0.44,0.33,0.44,0.25,0.55,0.5,0.5,0.28,0.44,0.28,0.5,0.44,0.5,0.25,0.55,0.33,0.33,0.5,0.78,0.25,0.55,0.67,0.72,0.25,0.55,0.67,0.28,0.5,0.39,0.44,0.28,0.33" y="640.3" x="355.9,358.9,361.7,370.4,375.7,379.8,385.1,388.1,390.9,396.9,402.9,406.3,411.6,415.0,421.0,426.3,432.3,435.3,438.1,442.1,446.1,452.1,461.4,464.4,467.2,475.2,483.9,486.9,489.7,497.7,501.1,507.1,511.8,517.1,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx"> were obtained from BD Biosci-</text>
  <text svgx:width="0.44,0.5,0.44,0.44,0.39,0.25,0.33,0.56,0.44,0.5,0.25,0.72,0.28,0.44,0.5,0.5,0.25,0.25,0.67,0.72,0.25,0.25,0.72,0.56,0.72,0.33,0.25,0.44,0.5,0.5,0.25,0.67,0.78,0.72,0.25,0.56,0.5,0.39,0.33" y="654.1" x="306.1,311.4,317.5,322.8,328.1,332.8,336.3,340.3,347.0,352.3,358.3,361.9,370.5,373.9,379.2,385.2,391.2,394.2,397.8,405.8,414.4,417.4,421.0,429.6,436.3,445.0,449.0,452.5,457.9,463.9,469.9,473.4,481.4,490.8,499.4,503.0,509.6,515.6,520.3" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ences (San Diego, CA, USA) and R&amp;D Sys-</text>
  <text svgx:width="0.28,0.44,0.78,0.39,0.25,0.25,0.55,0.33,0.5,0.44,0.25,0.25,0.55,0.33,0.56,0.28,0.25,0.25,0.55,0.61,0.5,0.5,0.28,0.39,0.25,0.25,0.55,0.89,0.72,0.25,0.25,0.55,0.72,0.56,0.72,0.33,0.25,0.25,0.55,0.72,0.5,0.28,0.28,0.5,0.5,0.5,0.39,0.33" y="667.9" x="306.1,309.5,314.8,324.0,328.7,331.7,334.7,336.0,340.0,346.0,351.3,354.3,357.3,358.6,362.6,369.3,372.6,375.6,378.6,379.9,387.2,393.2,399.2,402.6,407.2,410.2,413.2,414.5,425.2,433.8,436.8,439.8,441.1,449.8,456.4,465.1,469.1,472.1,475.1,476.4,485.0,491.1,494.4,497.7,503.7,509.8,515.8,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">tems, Inc. (St. Louis, MO, USA). Antiphos-</text>
  <text svgx:width="0.5,0.5,0.5,0.33,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.33,0.5,0.67,0.33,0.52,0.25,0.33,0.44,0.5,0.28,0.28,0.33,0.5,0.33,0.33,0.5,0.67,0.33,0.52,0.33,0.25,0.25,0.44,0.5,0.28,0.28,0.33,0.72,0.56,0.33,0.5,0.67,0.25,0.25" y="681.7" x="306.1,312.1,318.1,324.1,328.1,334.1,337.4,342.8,346.1,351.4,357.4,360.4,364.4,370.4,378.4,382.4,388.7,391.7,395.7,401.1,407.1,410.4,413.7,417.7,423.7,427.7,431.7,437.8,445.7,449.8,456.0,460.0,463.0,466.0,471.3,477.3,480.6,483.9,487.9,496.6,503.3,507.3,513.4,521.3,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">phorylated IκB-α (anti-p-IκB-α), anti-NF-κB, </text>
  <text svgx:width="0.44,0.5,0.28,0.28,0.33,0.39,0.72,0.72,0.25,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.5,0.5,0.5,0.25,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.61,0.67,0.72,0.5,0.28,0.5,0.25,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.5,0.5,0.5,0.39,0.33" y="695.4" x="306.1,311.5,317.5,320.8,324.1,328.1,332.8,341.5,350.1,353.1,356.1,358.2,363.5,369.5,372.9,376.2,380.2,386.2,392.2,398.2,401.2,404.2,406.3,411.6,417.6,421.0,424.3,428.3,435.7,443.7,452.3,458.3,461.7,467.7,470.7,473.7,475.8,481.1,487.1,490.4,493.8,497.8,503.8,509.8,515.8,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">anti-JNK, anti-p38, anti-ERK1/2, anti-phos-</text>
  <text svgx:width="0.5,0.5,0.5,0.33,0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.39,0.72,0.72,0.25,0.33,0.44,0.5,0.28,0.28,0.33,0.5,0.33,0.39,0.72,0.72,0.33,0.25,0.25,0.44,0.5,0.28,0.28,0.33,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.33" y="709.2" x="306.1,312.1,318.1,324.1,328.1,334.1,337.5,342.8,346.1,351.4,357.4,360.6,365.2,373.9,382.6,385.7,389.7,395.0,401.0,404.3,407.7,411.7,417.7,421.7,426.3,435.0,443.7,447.7,450.7,453.8,459.1,465.1,468.4,471.8,475.8,481.8,487.8,493.8,498.4,504.4,510.4,516.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">phorylated JNK (anti-p-JNK), anti-phosphor-</text>
  <text svgx:width="0.5,0.28,0.44,0.28,0.44,0.5,0.25,0.55,0.5,0.5,0.5,0.25,0.55,0.33,0.44,0.5,0.28,0.28,0.33,0.5,0.33,0.5,0.5,0.5,0.33,0.25,0.55,0.44,0.5,0.5,0.25,0.55,0.44,0.5,0.28,0.28,0.33,0.5,0.5,0.5,0.39,0.5,0.5,0.5,0.33,0.5,0.33" y="723.0" x="306.1,312.1,315.5,320.8,324.1,329.5,335.5,338.5,340.2,346.2,352.2,358.2,361.2,362.9,366.9,372.2,378.2,381.6,384.9,388.9,394.9,398.9,404.9,410.9,416.9,420.9,423.9,425.6,431.0,437.0,443.0,446.0,447.7,453.0,459.0,462.4,465.7,469.7,475.7,481.7,487.7,492.4,498.4,504.4,510.4,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ylated p38 (anti-p-p38) and anti-phosphory-</text>
  <text svgx:width="0.28,0.44,0.28,0.44,0.5,0.25,0.61,0.67,0.72,0.5,0.28,0.5,0.25,0.33,0.44,0.5,0.28,0.28,0.33,0.5,0.33,0.61,0.67,0.72,0.5,0.28,0.5,0.33,0.25,0.78,0.5,0.5,0.39,0.44,0.25,0.5,0.33,0.25,0.33,0.44,0.5,0.33" y="736.8" x="306.1,309.5,314.8,318.1,323.5,329.5,332.6,339.9,347.9,356.6,362.6,365.9,371.9,375.1,379.1,384.4,390.4,393.7,397.1,401.1,407.1,411.1,418.4,426.3,435.0,441.0,444.3,450.3,454.3,457.5,466.7,472.7,478.7,483.5,488.8,491.9,497.9,501.9,505.0,509.0,514.4,520.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">lated ERK1/2 (anti-p-ERK1/2) mouse or rab-</text>
  <text svgx:width="0.5,0.28,0.28,0.25,0.44,0.5,0.28,0.28,0.5,0.5,0.5,0.28,0.44,0.39,0.25,0.72,0.44,0.33,0.44,0.25,0.5,0.5,0.5,0.5,0.5,0.28,0.25,0.33,0.33,0.5,0.78,0.25,0.67,0.44,0.28,0.28,0.25,0.56,0.28,0.5,0.5,0.44,0.28,0.33" y="750.6" x="306.1,312.1,315.5,318.8,322.4,327.7,333.7,337.1,340.4,346.4,352.4,358.4,361.8,367.1,371.8,375.4,384.1,389.4,393.4,398.7,402.3,408.3,414.3,420.3,426.3,432.3,435.7,439.3,443.3,447.3,453.3,462.5,466.2,474.2,479.5,482.8,486.2,489.8,496.5,499.8,505.8,511.8,517.1,520.5" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">bit antibodies were bought from Cell Signal-</text>
  <text svgx:width="0.28,0.5,0.5,0.25,0.55,0.61,0.44,0.44,0.5,0.5,0.5,0.28,0.5,0.5,0.5,0.25,0.55,0.33,0.67,0.44,0.5,0.44,0.33,0.28,0.5,0.25,0.25,0.55,0.89,0.72,0.25,0.25,0.55,0.72,0.56,0.72,0.33,0.25,0.25,0.55,0.72,0.28,0.28,0.25" y="764.4" x="306.1,309.5,315.5,321.5,324.5,327.8,335.2,340.5,345.8,351.8,357.8,363.8,367.2,373.2,379.2,385.2,388.2,391.5,395.5,403.5,408.9,414.9,420.2,424.2,427.5,433.5,436.5,439.5,442.9,453.6,462.2,465.2,468.2,471.6,480.3,487.0,495.6,499.6,502.6,505.6,509.0,517.7,521.0,524.4" style="fill:rgb(0,0,0);font-family:TimesNewRomanPSMT;font-size:12.0px;stroke:none;" xmlns:svgx="http://www.xml-cml.org/schema/svgx">ing Technology (Beverly, MA, USA). All </text>
 </g>
</svg>
